SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
3.060
+0.050 (1.66%)
At close: Oct 15, 2026, 4:00 PM EDT
3.070
+0.010 (0.33%)
After-hours: Oct 15, 2026, 6:05 PM EDT
SeaStar Medical Holding Revenue
SeaStar Medical Holding had revenue of $615.00K in the quarter ending June 30, 2026, with 81.95% growth. This brings the company's revenue in the last twelve months to $1.71M, up 123.63% year-over-year. In the year 2025, SeaStar Medical Holding had annual revenue of $1.23M with 814.07% growth. That makes SeaStar Medical Holding the 42,644th largest company in the world by revenue and 5,845th in the United States.
Revenue (ttm)
$1.71M
Revenue Growth
+123.63%
P/S Ratio
9.40
Revenue / Employee
$95,167
Employees
18
Market Cap
16.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.23M | 1.10M | 814.07% |
| Dec 31, 2024 | 135.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Radiopharm Theranostics | 8.90M |
| TScan Therapeutics | 7.11M |
| Dyadic International | 3.80M |
| Marker Therapeutics | 3.55M |
| Daré Bioscience | 1.37M |
| Neuphoria Therapeutics | 1.17M |
| Kiora Pharmaceuticals | 20.00K |
ICU News
- 1 day ago - SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award - GlobeNewsWire
- 8 days ago - SeaStar Medical granted Breakthrough Device Designation for SCD therapy - TheFly
- 8 days ago - FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition - GlobeNewsWire
- 10 days ago - SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds - GlobeNewsWire
- 13 days ago - SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026 - GlobeNewsWire
- 14 days ago - SeaStar Medical announces codes available for use of SCD therapy for AKI - TheFly
- 14 days ago - New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical's SCD Therapy for Acute Kidney Injury (AKI) - GlobeNewsWire
- 16 days ago - SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026 - GlobeNewsWire